Carna Biosciences, Inc.
Carna Biosciences, Inc. CBIXF Peers
See (CBIXF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CBIXF | $10.75 | N/A | N/A | -71.67 | -$0.15 | N/A |
| NONOF | $66.23 | -1.79% | 294.01B | 18.76 | $3.53 | +2.50% |
| CSLLY | $79.39 | +1.65% | 153.77B | 29.08 | $2.73 | +1.67% |
| CMXHF | $152.32 | +0.90% | 73.75B | 27.95 | $5.45 | +1.68% |
| UCBJY | $90.98 | -1.30% | 34.58B | 29.54 | $3.08 | +0.60% |
| ARGNF | $562.00 | N/A | 34.32B | 34.25 | $16.41 | N/A |
| UCBJF | $175.75 | N/A | 33.40B | 28.67 | $6.13 | +0.71% |
| ODTC | $22,005.00 | +29.44% | 24.14B | -0.08 | -$268,995.00 | N/A |
| GNMSF | $208.35 | +4.51% | 12.81B | 12.23 | $17.04 | N/A |
| WXXWY | $6.12 | -2.92% | 12.45B | 27.80 | $0.22 | N/A |
Stock Comparison
CBIXF vs NONOF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, NONOF has a market cap of 294.01B. Regarding current trading prices, CBIXF is priced at $10.75, while NONOF trades at $66.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas NONOF's P/E ratio is 18.76. In terms of profitability, CBIXF's ROE is N/A, compared to NONOF's ROE of +0.81%. Regarding short-term risk, CBIXF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CSLLY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CSLLY has a market cap of 153.77B. Regarding current trading prices, CBIXF is priced at $10.75, while CSLLY trades at $79.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CSLLY's P/E ratio is 29.08. In terms of profitability, CBIXF's ROE is N/A, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, CBIXF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CMXHF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CMXHF has a market cap of 73.75B. Regarding current trading prices, CBIXF is priced at $10.75, while CMXHF trades at $152.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CMXHF's P/E ratio is 27.95. In terms of profitability, CBIXF's ROE is N/A, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, CBIXF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs UCBJY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, UCBJY has a market cap of 34.58B. Regarding current trading prices, CBIXF is priced at $10.75, while UCBJY trades at $90.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas UCBJY's P/E ratio is 29.54. In terms of profitability, CBIXF's ROE is N/A, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, CBIXF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ARGNF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ARGNF has a market cap of 34.32B. Regarding current trading prices, CBIXF is priced at $10.75, while ARGNF trades at $562.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, CBIXF's ROE is N/A, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, CBIXF and ARGNF have similar daily volatility (0.00).
CBIXF vs UCBJF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, UCBJF has a market cap of 33.40B. Regarding current trading prices, CBIXF is priced at $10.75, while UCBJF trades at $175.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas UCBJF's P/E ratio is 28.67. In terms of profitability, CBIXF's ROE is N/A, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, CBIXF is less volatile compared to UCBJF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ODTC Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ODTC has a market cap of 24.14B. Regarding current trading prices, CBIXF is priced at $10.75, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ODTC's P/E ratio is -0.08. In terms of profitability, CBIXF's ROE is N/A, compared to ODTC's ROE of +0.07%. Regarding short-term risk, CBIXF and ODTC have similar daily volatility (0.00).
CBIXF vs GNMSF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, GNMSF has a market cap of 12.81B. Regarding current trading prices, CBIXF is priced at $10.75, while GNMSF trades at $208.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas GNMSF's P/E ratio is 12.23. In terms of profitability, CBIXF's ROE is N/A, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, CBIXF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs WXXWY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, WXXWY has a market cap of 12.45B. Regarding current trading prices, CBIXF is priced at $10.75, while WXXWY trades at $6.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas WXXWY's P/E ratio is 27.80. In terms of profitability, CBIXF's ROE is N/A, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, CBIXF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs WXIBF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, WXIBF has a market cap of 12.19B. Regarding current trading prices, CBIXF is priced at $10.75, while WXIBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, CBIXF's ROE is N/A, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, CBIXF and WXIBF have similar daily volatility (0.00).
CBIXF vs IVBXF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, IVBXF has a market cap of 11.67B. Regarding current trading prices, CBIXF is priced at $10.75, while IVBXF trades at $7.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas IVBXF's P/E ratio is -707.54. In terms of profitability, CBIXF's ROE is N/A, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, CBIXF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs SBMFF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SBMFF has a market cap of 8.86B. Regarding current trading prices, CBIXF is priced at $10.75, while SBMFF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SBMFF's P/E ratio is 49.50. In terms of profitability, CBIXF's ROE is N/A, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, CBIXF is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs SBHMY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SBHMY has a market cap of 8.48B. Regarding current trading prices, CBIXF is priced at $10.75, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, CBIXF's ROE is N/A, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, CBIXF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs TRSBF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, TRSBF has a market cap of 6.46B. Regarding current trading prices, CBIXF is priced at $10.75, while TRSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas TRSBF's P/E ratio is 30.44. In terms of profitability, CBIXF's ROE is N/A, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, CBIXF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs TLPPF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, TLPPF has a market cap of 5.66B. Regarding current trading prices, CBIXF is priced at $10.75, while TLPPF trades at $16.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas TLPPF's P/E ratio is 186.11. In terms of profitability, CBIXF's ROE is N/A, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, CBIXF and TLPPF have similar daily volatility (0.00).
CBIXF vs ABCZF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ABCZF has a market cap of 5.12B. Regarding current trading prices, CBIXF is priced at $10.75, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, CBIXF's ROE is N/A, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, CBIXF and ABCZF have similar daily volatility (0.00).
CBIXF vs INCPF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, INCPF has a market cap of 4.88B. Regarding current trading prices, CBIXF is priced at $10.75, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas INCPF's P/E ratio is -108.67. In terms of profitability, CBIXF's ROE is N/A, compared to INCPF's ROE of -0.05%. Regarding short-term risk, CBIXF and INCPF have similar daily volatility (0.00).
CBIXF vs AKBLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, AKBLF has a market cap of 4.75B. Regarding current trading prices, CBIXF is priced at $10.75, while AKBLF trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas AKBLF's P/E ratio is 33.89. In terms of profitability, CBIXF's ROE is N/A, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, CBIXF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs LABFF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, LABFF has a market cap of 4.63B. Regarding current trading prices, CBIXF is priced at $10.75, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas LABFF's P/E ratio is 28.95. In terms of profitability, CBIXF's ROE is N/A, compared to LABFF's ROE of +0.39%. Regarding short-term risk, CBIXF and LABFF have similar daily volatility (0.00).
CBIXF vs ZLDPF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ZLDPF has a market cap of 4.41B. Regarding current trading prices, CBIXF is priced at $10.75, while ZLDPF trades at $62.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ZLDPF's P/E ratio is -24.07. In terms of profitability, CBIXF's ROE is N/A, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, CBIXF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs SHJBF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SHJBF has a market cap of 3.50B. Regarding current trading prices, CBIXF is priced at $10.75, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, CBIXF's ROE is N/A, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, CBIXF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CAMRF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CAMRF has a market cap of 3.28B. Regarding current trading prices, CBIXF is priced at $10.75, while CAMRF trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CAMRF's P/E ratio is 59.57. In terms of profitability, CBIXF's ROE is N/A, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, CBIXF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs REGMF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, REGMF has a market cap of 3.27B. Regarding current trading prices, CBIXF is priced at $10.75, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas REGMF's P/E ratio is -13.32. In terms of profitability, CBIXF's ROE is N/A, compared to REGMF's ROE of -0.48%. Regarding short-term risk, CBIXF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs GNNSF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, GNNSF has a market cap of 2.91B. Regarding current trading prices, CBIXF is priced at $10.75, while GNNSF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, CBIXF's ROE is N/A, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, CBIXF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs TKBIF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, TKBIF has a market cap of 2.79B. Regarding current trading prices, CBIXF is priced at $10.75, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, CBIXF's ROE is N/A, compared to TKBIF's ROE of N/A. Regarding short-term risk, CBIXF and TKBIF have similar daily volatility (0.00).
CBIXF vs MPSYF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, MPSYF has a market cap of 2.76B. Regarding current trading prices, CBIXF is priced at $10.75, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, CBIXF's ROE is N/A, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, CBIXF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ASPHF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ASPHF has a market cap of 2.24B. Regarding current trading prices, CBIXF is priced at $10.75, while ASPHF trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, CBIXF's ROE is N/A, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, CBIXF and ASPHF have similar daily volatility (0.00).
CBIXF vs BVNKF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BVNKF has a market cap of 2.09B. Regarding current trading prices, CBIXF is priced at $10.75, while BVNKF trades at $26.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BVNKF's P/E ratio is 10.63. In terms of profitability, CBIXF's ROE is N/A, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, CBIXF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs BVNRY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BVNRY has a market cap of 1.98B. Regarding current trading prices, CBIXF is priced at $10.75, while BVNRY trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BVNRY's P/E ratio is 10.12. In terms of profitability, CBIXF's ROE is N/A, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, CBIXF and BVNRY have similar daily volatility (0.00).
CBIXF vs BTTAY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BTTAY has a market cap of 1.92B. Regarding current trading prices, CBIXF is priced at $10.75, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BTTAY's P/E ratio is -69.23. In terms of profitability, CBIXF's ROE is N/A, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, CBIXF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs GENSF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, GENSF has a market cap of 1.83B. Regarding current trading prices, CBIXF is priced at $10.75, while GENSF trades at $27.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas GENSF's P/E ratio is -348.31. In terms of profitability, CBIXF's ROE is N/A, compared to GENSF's ROE of +0.01%. Regarding short-term risk, CBIXF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs MEOBF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, MEOBF has a market cap of 1.82B. Regarding current trading prices, CBIXF is priced at $10.75, while MEOBF trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, CBIXF's ROE is N/A, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, CBIXF is less volatile compared to MEOBF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs GLPGF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, GLPGF has a market cap of 1.81B. Regarding current trading prices, CBIXF is priced at $10.75, while GLPGF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas GLPGF's P/E ratio is -9.02. In terms of profitability, CBIXF's ROE is N/A, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, CBIXF is less volatile compared to GLPGF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs PPTDF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PPTDF has a market cap of 1.75B. Regarding current trading prices, CBIXF is priced at $10.75, while PPTDF trades at $13.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PPTDF's P/E ratio is 17.35. In terms of profitability, CBIXF's ROE is N/A, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, CBIXF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs BRCTF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BRCTF has a market cap of 1.64B. Regarding current trading prices, CBIXF is priced at $10.75, while BRCTF trades at $18.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BRCTF's P/E ratio is -88.19. In terms of profitability, CBIXF's ROE is N/A, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, CBIXF and BRCTF have similar daily volatility (0.00).
CBIXF vs ONTTF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ONTTF has a market cap of 1.64B. Regarding current trading prices, CBIXF is priced at $10.75, while ONTTF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ONTTF's P/E ratio is -8.11. In terms of profitability, CBIXF's ROE is N/A, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, CBIXF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs BIESF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BIESF has a market cap of 1.62B. Regarding current trading prices, CBIXF is priced at $10.75, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BIESF's P/E ratio is -45.71. In terms of profitability, CBIXF's ROE is N/A, compared to BIESF's ROE of +0.05%. Regarding short-term risk, CBIXF and BIESF have similar daily volatility (0.00).
CBIXF vs PHMMF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PHMMF has a market cap of 1.42B. Regarding current trading prices, CBIXF is priced at $10.75, while PHMMF trades at $80.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PHMMF's P/E ratio is 64.21. In terms of profitability, CBIXF's ROE is N/A, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, CBIXF is less volatile compared to PHMMF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CSBTF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CSBTF has a market cap of 1.15B. Regarding current trading prices, CBIXF is priced at $10.75, while CSBTF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, CBIXF's ROE is N/A, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, CBIXF and CSBTF have similar daily volatility (0.00).
CBIXF vs NURPF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, NURPF has a market cap of 1.02B. Regarding current trading prices, CBIXF is priced at $10.75, while NURPF trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas NURPF's P/E ratio is 11.63. In terms of profitability, CBIXF's ROE is N/A, compared to NURPF's ROE of +0.49%. Regarding short-term risk, CBIXF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs SNBIF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SNBIF has a market cap of 1.00B. Regarding current trading prices, CBIXF is priced at $10.75, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, CBIXF's ROE is N/A, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, CBIXF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ASCLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ASCLF has a market cap of 865.80M. Regarding current trading prices, CBIXF is priced at $10.75, while ASCLF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ASCLF's P/E ratio is -22.33. In terms of profitability, CBIXF's ROE is N/A, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, CBIXF is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CSPHF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CSPHF has a market cap of 702.96M. Regarding current trading prices, CBIXF is priced at $10.75, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, CBIXF's ROE is N/A, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, CBIXF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs PHGUF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PHGUF has a market cap of 680.31M. Regarding current trading prices, CBIXF is priced at $10.75, while PHGUF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, CBIXF's ROE is N/A, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, CBIXF and PHGUF have similar daily volatility (0.00).
CBIXF vs BPMUF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BPMUF has a market cap of 582.74M. Regarding current trading prices, CBIXF is priced at $10.75, while BPMUF trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BPMUF's P/E ratio is 6.85. In terms of profitability, CBIXF's ROE is N/A, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, CBIXF is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs INRLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, INRLF has a market cap of 543.23M. Regarding current trading prices, CBIXF is priced at $10.75, while INRLF trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas INRLF's P/E ratio is -5.16. In terms of profitability, CBIXF's ROE is N/A, compared to INRLF's ROE of -0.43%. Regarding short-term risk, CBIXF and INRLF have similar daily volatility (0.00).
CBIXF vs SOLTF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SOLTF has a market cap of 534.16M. Regarding current trading prices, CBIXF is priced at $10.75, while SOLTF trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SOLTF's P/E ratio is -32.83. In terms of profitability, CBIXF's ROE is N/A, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, CBIXF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs BXPHF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BXPHF has a market cap of 517.79M. Regarding current trading prices, CBIXF is priced at $10.75, while BXPHF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BXPHF's P/E ratio is -26.50. In terms of profitability, CBIXF's ROE is N/A, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, CBIXF is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs IVEVF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, IVEVF has a market cap of 505.87M. Regarding current trading prices, CBIXF is priced at $10.75, while IVEVF trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, CBIXF's ROE is N/A, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, CBIXF and IVEVF have similar daily volatility (0.00).
CBIXF vs CLTEF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CLTEF has a market cap of 504.72M. Regarding current trading prices, CBIXF is priced at $10.75, while CLTEF trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, CBIXF's ROE is N/A, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, CBIXF and CLTEF have similar daily volatility (0.00).
CBIXF vs CKDXF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CKDXF has a market cap of 470.61M. Regarding current trading prices, CBIXF is priced at $10.75, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, CBIXF's ROE is N/A, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, CBIXF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs AAVXF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, AAVXF has a market cap of 457.38M. Regarding current trading prices, CBIXF is priced at $10.75, while AAVXF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas AAVXF's P/E ratio is -2.30. In terms of profitability, CBIXF's ROE is N/A, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, CBIXF and AAVXF have similar daily volatility (0.00).
CBIXF vs VBIZF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, VBIZF has a market cap of 456.09M. Regarding current trading prices, CBIXF is priced at $10.75, while VBIZF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas VBIZF's P/E ratio is 21.89. In terms of profitability, CBIXF's ROE is N/A, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, CBIXF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs TBGNF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, TBGNF has a market cap of 433.72M. Regarding current trading prices, CBIXF is priced at $10.75, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, CBIXF's ROE is N/A, compared to TBGNF's ROE of N/A. Regarding short-term risk, CBIXF and TBGNF have similar daily volatility (0.00).
CBIXF vs CYDY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CYDY has a market cap of 428.05M. Regarding current trading prices, CBIXF is priced at $10.75, while CYDY trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CYDY's P/E ratio is -17.37. In terms of profitability, CBIXF's ROE is N/A, compared to CYDY's ROE of +0.07%. Regarding short-term risk, CBIXF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs HBMHF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, HBMHF has a market cap of 407.69M. Regarding current trading prices, CBIXF is priced at $10.75, while HBMHF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, CBIXF's ROE is N/A, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, CBIXF and HBMHF have similar daily volatility (0.00).
CBIXF vs PTCHF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PTCHF has a market cap of 403.52M. Regarding current trading prices, CBIXF is priced at $10.75, while PTCHF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, CBIXF's ROE is N/A, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, CBIXF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs NWBO Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, NWBO has a market cap of 403.08M. Regarding current trading prices, CBIXF is priced at $10.75, while NWBO trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas NWBO's P/E ratio is -4.66. In terms of profitability, CBIXF's ROE is N/A, compared to NWBO's ROE of +1.13%. Regarding short-term risk, CBIXF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs IDRSF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, IDRSF has a market cap of 377.58M. Regarding current trading prices, CBIXF is priced at $10.75, while IDRSF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas IDRSF's P/E ratio is -1.04. In terms of profitability, CBIXF's ROE is N/A, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, CBIXF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CLVLY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CLVLY has a market cap of 359.89M. Regarding current trading prices, CBIXF is priced at $10.75, while CLVLY trades at $7.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CLVLY's P/E ratio is 14.65. In terms of profitability, CBIXF's ROE is N/A, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, CBIXF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CLVLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CLVLF has a market cap of 348.36M. Regarding current trading prices, CBIXF is priced at $10.75, while CLVLF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, CBIXF's ROE is N/A, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, CBIXF and CLVLF have similar daily volatility (0.00).
CBIXF vs PRRUF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PRRUF has a market cap of 309.60M. Regarding current trading prices, CBIXF is priced at $10.75, while PRRUF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PRRUF's P/E ratio is -10.60. In terms of profitability, CBIXF's ROE is N/A, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, CBIXF and PRRUF have similar daily volatility (0.00).
CBIXF vs BOVNF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BOVNF has a market cap of 309.28M. Regarding current trading prices, CBIXF is priced at $10.75, while BOVNF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, CBIXF's ROE is N/A, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, CBIXF and BOVNF have similar daily volatility (0.00).
CBIXF vs NGENF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, NGENF has a market cap of 287.30M. Regarding current trading prices, CBIXF is priced at $10.75, while NGENF trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas NGENF's P/E ratio is -14.80. In terms of profitability, CBIXF's ROE is N/A, compared to NGENF's ROE of -2.23%. Regarding short-term risk, CBIXF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs PBBIF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PBBIF has a market cap of 286.93M. Regarding current trading prices, CBIXF is priced at $10.75, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, CBIXF's ROE is N/A, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, CBIXF is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ORYZF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ORYZF has a market cap of 234.86M. Regarding current trading prices, CBIXF is priced at $10.75, while ORYZF trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, CBIXF's ROE is N/A, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, CBIXF and ORYZF have similar daily volatility (0.00).
CBIXF vs NWPHF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, NWPHF has a market cap of 231.22M. Regarding current trading prices, CBIXF is priced at $10.75, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas NWPHF's P/E ratio is N/A. In terms of profitability, CBIXF's ROE is N/A, compared to NWPHF's ROE of N/A. Regarding short-term risk, CBIXF and NWPHF have similar daily volatility (0.00).
CBIXF vs MDCLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, MDCLF has a market cap of 230.69M. Regarding current trading prices, CBIXF is priced at $10.75, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, CBIXF's ROE is N/A, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, CBIXF is less volatile compared to MDCLF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs HLOSF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, HLOSF has a market cap of 228.29M. Regarding current trading prices, CBIXF is priced at $10.75, while HLOSF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas HLOSF's P/E ratio is -7.26. In terms of profitability, CBIXF's ROE is N/A, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, CBIXF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs SPHDF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SPHDF has a market cap of 225.73M. Regarding current trading prices, CBIXF is priced at $10.75, while SPHDF trades at $17.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SPHDF's P/E ratio is -3.99. In terms of profitability, CBIXF's ROE is N/A, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, CBIXF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs RAONF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, RAONF has a market cap of 211.95M. Regarding current trading prices, CBIXF is priced at $10.75, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas RAONF's P/E ratio is -20.33. In terms of profitability, CBIXF's ROE is N/A, compared to RAONF's ROE of -0.71%. Regarding short-term risk, CBIXF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs FPHAF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, FPHAF has a market cap of 209.54M. Regarding current trading prices, CBIXF is priced at $10.75, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, CBIXF's ROE is N/A, compared to FPHAF's ROE of N/A. Regarding short-term risk, CBIXF and FPHAF have similar daily volatility (0.00).
CBIXF vs VSBC Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, VSBC has a market cap of 207.03M. Regarding current trading prices, CBIXF is priced at $10.75, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas VSBC's P/E ratio is N/A. In terms of profitability, CBIXF's ROE is N/A, compared to VSBC's ROE of +0.00%. Regarding short-term risk, CBIXF and VSBC have similar daily volatility (0.00).
CBIXF vs FGHQF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, FGHQF has a market cap of 205.61M. Regarding current trading prices, CBIXF is priced at $10.75, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, CBIXF's ROE is N/A, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, CBIXF is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs HNSBF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, HNSBF has a market cap of 203.44M. Regarding current trading prices, CBIXF is priced at $10.75, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, CBIXF's ROE is N/A, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, CBIXF is less volatile compared to HNSBF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs BSEM Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BSEM has a market cap of 196.06M. Regarding current trading prices, CBIXF is priced at $10.75, while BSEM trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BSEM's P/E ratio is -21.05. In terms of profitability, CBIXF's ROE is N/A, compared to BSEM's ROE of +1.50%. Regarding short-term risk, CBIXF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs GNFTF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, GNFTF has a market cap of 176.25M. Regarding current trading prices, CBIXF is priced at $10.75, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, CBIXF's ROE is N/A, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, CBIXF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs SCNLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SCNLF has a market cap of 176.05M. Regarding current trading prices, CBIXF is priced at $10.75, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, CBIXF's ROE is N/A, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, CBIXF and SCNLF have similar daily volatility (0.00).
CBIXF vs OPORF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, OPORF has a market cap of 164.88M. Regarding current trading prices, CBIXF is priced at $10.75, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas OPORF's P/E ratio is 12.00. In terms of profitability, CBIXF's ROE is N/A, compared to OPORF's ROE of +0.42%. Regarding short-term risk, CBIXF is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs MLLCF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, MLLCF has a market cap of 155.61M. Regarding current trading prices, CBIXF is priced at $10.75, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas MLLCF's P/E ratio is -2.08. In terms of profitability, CBIXF's ROE is N/A, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, CBIXF is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs AVCTF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, AVCTF has a market cap of 153.80M. Regarding current trading prices, CBIXF is priced at $10.75, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, CBIXF's ROE is N/A, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, CBIXF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs RECEF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, RECEF has a market cap of 149.84M. Regarding current trading prices, CBIXF is priced at $10.75, while RECEF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas RECEF's P/E ratio is -10.00. In terms of profitability, CBIXF's ROE is N/A, compared to RECEF's ROE of +2.26%. Regarding short-term risk, CBIXF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs SLNCF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, SLNCF has a market cap of 137.44M. Regarding current trading prices, CBIXF is priced at $10.75, while SLNCF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas SLNCF's P/E ratio is -1.90. In terms of profitability, CBIXF's ROE is N/A, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, CBIXF is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs BRIBF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, BRIBF has a market cap of 134.10M. Regarding current trading prices, CBIXF is priced at $10.75, while BRIBF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, CBIXF's ROE is N/A, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, CBIXF and BRIBF have similar daily volatility (0.00).
CBIXF vs IPHYF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, IPHYF has a market cap of 133.63M. Regarding current trading prices, CBIXF is priced at $10.75, while IPHYF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas IPHYF's P/E ratio is -2.13. In terms of profitability, CBIXF's ROE is N/A, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, CBIXF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs AAPGV Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, AAPGV has a market cap of 127.31M. Regarding current trading prices, CBIXF is priced at $10.75, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas AAPGV's P/E ratio is N/A. In terms of profitability, CBIXF's ROE is N/A, compared to AAPGV's ROE of N/A. Regarding short-term risk, CBIXF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs PRNAF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PRNAF has a market cap of 126.87M. Regarding current trading prices, CBIXF is priced at $10.75, while PRNAF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, CBIXF's ROE is N/A, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, CBIXF and PRNAF have similar daily volatility (0.00).
CBIXF vs AMGXF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, AMGXF has a market cap of 121.79M. Regarding current trading prices, CBIXF is priced at $10.75, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, CBIXF's ROE is N/A, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, CBIXF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs PSTTF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PSTTF has a market cap of 117.53M. Regarding current trading prices, CBIXF is priced at $10.75, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, CBIXF's ROE is N/A, compared to PSTTF's ROE of N/A. Regarding short-term risk, CBIXF and PSTTF have similar daily volatility (0.00).
CBIXF vs EPRXF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, EPRXF has a market cap of 108.29M. Regarding current trading prices, CBIXF is priced at $10.75, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, CBIXF's ROE is N/A, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, CBIXF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ADOIF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ADOIF has a market cap of 103.66M. Regarding current trading prices, CBIXF is priced at $10.75, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, CBIXF's ROE is N/A, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, CBIXF and ADOIF have similar daily volatility (0.00).
CBIXF vs PBIGF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, PBIGF has a market cap of 100.04M. Regarding current trading prices, CBIXF is priced at $10.75, while PBIGF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, CBIXF's ROE is N/A, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, CBIXF is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ADOCY Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ADOCY has a market cap of 98.20M. Regarding current trading prices, CBIXF is priced at $10.75, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, CBIXF's ROE is N/A, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, CBIXF and ADOCY have similar daily volatility (0.00).
CBIXF vs TRGNF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, TRGNF has a market cap of 92.35M. Regarding current trading prices, CBIXF is priced at $10.75, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas TRGNF's P/E ratio is -2.19. In terms of profitability, CBIXF's ROE is N/A, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, CBIXF is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs CMVLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, CMVLF has a market cap of 90.12M. Regarding current trading prices, CBIXF is priced at $10.75, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas CMVLF's P/E ratio is -3.05. In terms of profitability, CBIXF's ROE is N/A, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, CBIXF and CMVLF have similar daily volatility (0.00).
CBIXF vs IUGNF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, IUGNF has a market cap of 88.86M. Regarding current trading prices, CBIXF is priced at $10.75, while IUGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas IUGNF's P/E ratio is -1.19. In terms of profitability, CBIXF's ROE is N/A, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, CBIXF is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs MCURF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, MCURF has a market cap of 86.53M. Regarding current trading prices, CBIXF is priced at $10.75, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas MCURF's P/E ratio is -16.90. In terms of profitability, CBIXF's ROE is N/A, compared to MCURF's ROE of -1.02%. Regarding short-term risk, CBIXF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs MSCLF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, MSCLF has a market cap of 84.58M. Regarding current trading prices, CBIXF is priced at $10.75, while MSCLF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas MSCLF's P/E ratio is 2.83. In terms of profitability, CBIXF's ROE is N/A, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, CBIXF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.
CBIXF vs ACHFF Comparison
CBIXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CBIXF stands at N/A. In comparison, ACHFF has a market cap of 81.06M. Regarding current trading prices, CBIXF is priced at $10.75, while ACHFF trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CBIXF currently has a P/E ratio of -71.67, whereas ACHFF's P/E ratio is -30.75. In terms of profitability, CBIXF's ROE is N/A, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, CBIXF is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for CBIXF.